Aberrant activation of the PI3K/AKT/HIF‑1α pathway promotes glycolysis and lenvatinib resistance in liver cancer.

Mol Med Rep · 2025 · PMC12434331 · PMID 40878941

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

did not reach statistical significanceP=0.053so close (0.05 < p ≤ 0.1)

A similar trend was observed in HepG2-LR cells, although the reduction in GLUT1 expression compared with the control group did not reach statistical significance ( Fig. 4H ; P=0.053).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.